Uhrenholt, L, Christensen, R, Dinesen, W K H, Liboriussen, C H, Andersen, S S, Dreyer, L, Schlemmer, A, Hauge, E-M, Skrubbeltrang, C, Taylor, P C & Kristensen, S 2022, ' Risk of flare after tapering or withdrawal of biologic/targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis or axial spondyloarthritis : a systematic review and meta-analysis ', Rheumatology, vol. 61, no. 8, pp. 3107-3122 . https://doi.org/10.1093/rheumatology/keab902 Uhrenholt, L, Christensen, R, Dinesen, W K H, Liboriussen, C H, Andersen, S S, Dreyer, L, Schlemmer, A, Hauge, E-M, Skrubbeltrang, C, Taylor, P C & Kristensen, S 2022, ' Risk of flare after tapering or withdrawal of biologic/targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis or axial spondyloarthritis : A systematic review and meta-analysis ', Rheumatology, vol. 61, no. 8, pp. 3107–3122 . https://doi.org/10.1093/rheumatology/keab902
Uhrenholt, L, Christensen, R, Dreyer, L, Schlemmer, A, Hauge, E M, Krogh, N S, Abildtoft, M K, Taylor, P C & Kristensen, S 2022, ' Using a novel smartphone application for capturing of patient-reported outcome measures among patients with inflammatory arthritis:A randomized, crossover, agreement study ', Scandinavian Journal of Rheumatology, vol. 51, no. 1, pp. 25-33 . https://doi.org/10.1080/03009742.2021.1907925 Uhrenholt, L, Christensen, R, Dreyer, L, Schlemmer, A, Hauge, E-M, Krogh, N S, Abildtoft, M K, Taylor, P C & Kristensen, S 2022, ' Using a novel smartphone application for capturing of patient-reported outcome measures among patients with inflammatory arthritis: A randomized, crossover, agreement study ', Scandinavian Journal of Rheumatology, vol. 51, no. 1, pp. 25-33 . https://doi.org/10.1080/03009742.2021.1907925 Uhrenholt, L, Christensen, R, Dreyer, L, Schlemmer, A, Hauge, E-M, Krogh, NS, Abildtoft, MK, Taylor, PC & Kristensen, S 2022, ' Using a novel smartphone application for capturing of patient-reported outcome measures among patients with inflammatory arthritis:A randomized, crossover, agreement study ', Scandinavian Journal of Rheumatology, vol. 51, no. 1, pp. 25-33 . https://doi.org/10.1080/03009742.2021.1907925
Eriksen, T E, Dinesen, W K H, Uhrenholt, L, Dreyer, L, Duch, K & Kristensen, S 2022, ' Isolation in patients with inflammatory rheumatic diseases during COVID-19 pandemic compared to healthy individuals : a questionnaire survey ', Rheumatology International, vol. 42, no. 5, pp. 783-790 . https://doi.org/10.1007/s00296-022-05111-6
Uhrenholt, L, Høstgaard, S, Pedersen, J F, Christensen, R, Dreyer, L, Leffers, H C B, Taylor, P C, Strand, V, Jacobsen, S, Voss, A, Gregersen, J W & Kristensen, S 2021, ' Patient-reported outcome measures in systemic lupus erythematosus by a web-based application : A randomized, crossover, agreement study ', Lupus, vol. 30, no. 13, pp. 2124-2134 . https://doi.org/10.1177/09612033211051641
Hetland, M L, Haavardsholm, E A, Rudin, A, Nordström, D, Nurmohamed, M, Gudbjornsson, B, Lampa, J, Hørslev-Petersen, K, Uhlig, T, Grondal, G, Østergaard, M, Heiberg, M S, Twisk, J, Lend, K, Krabbe, S, Hyldstrup, L H, Lindqvist, J, Hultgård Ekwall, A K, Grøn, K L, Kapetanovic, M, Faustini, F, Tuompo, R, Lorenzen, T, Cagnotto, G, Baecklund, E, Hendricks, O, Vedder, D, Sokka-Isler, T, Husmark, T, Ljoså, M K A, Brodin, E, Ellingsen, T, Söderbergh, A, Rizk, M, Olsson, Å R, Larsson, P, Uhrenholt, L, Just, S A, Stevens, D J, Laurberg, T B, Bakland, G, Olsen, I C, van Vollenhoven, R & NORD-STAR Study Group 2020, ' Active conventional treatment and three different biological treatments in early rheumatoid arthritis : phase IV investigator initiated, randomised, observer blinded clinical trial ', B M J, vol. 371, m4328 . https://doi.org/10.1136/bmj.m4328 BMJ. British Medical Journal BMJ (Clinical research ed.), 371:m4328. British Medical Association Hetland, M L, Haavardsholm, E A, Rudin, A, Nordström, D, Nurmohamed, M, Gudbjornsson, B, Lampa, J, Hørslev-Petersen, K, Uhlig, T, Grondal, G, Østergaard, M, Heiberg, M S, Twisk, J, Lend, K, Krabbe, S, Hyldstrup, L H, Lindqvist, J, Hultgård Ekwall, A-K, Grøn, K L, Kapetanovic, M, Faustini, F, Tuompo, R, Lorenzen, T, Cagnotto, G, Baecklund, E, Hendricks, O, Vedder, D, Sokka-Isler, T, Husmark, T, Ljoså, M-K A, Brodin, E, Ellingsen, T, Söderbergh, A, Rizk, M, Olsson, Å R, Larsson, P, Uhrenholt, L, Just, S A, Stevens, D J, Laurberg, T B, Bakland, G, Olsen, I C, van Vollenhoven, R & NORD-STAR Study Group 2020, ' Active conventional treatment and three different biological treatments in early rheumatoid arthritis : phase IV investigator initiated, randomised, observer blinded clinical trial ', The BMJ, vol. 371, m4328 . https://doi.org/10.1136/bmj.m4328 Hetland, M L, Haavardsholm, E A, Rudin, A, Nordström, D, Nurmohamed, M, Gudbjornsson, B, Lampa, J, Hørslev-Petersen, K, Uhlig, T, Grondal, G, Østergaard, M, Heiberg, M S, Twisk, J, Lend, K, Krabbe, S, Hyldstrup, L H, Lindqvist, J, Hultgård Ekwall, A K, Grøn, K L, Kapetanovic, M, Faustini, F, Tuompo, R, Lorenzen, T, Cagnotto, G, Baecklund, E, Hendricks, O, Vedder, D, Sokka-Isler, T, Husmark, T, Ljoså, M K A, Brodin, E, Ellingsen, T, Söderbergh, A, Rizk, M, Olsson, Å R, Larsson, P, Uhrenholt, L, Just, S A, Stevens, D J, Laurberg, T B, Bakland, G, Olsen, I C & Van Vollenhoven, R 2020, ' Active conventional treatment and three different biological treatments in early rheumatoid arthritis : Phase IV investigator initiated, randomised, observer blinded clinical trial ', The BMJ, vol. 371, m4328 . https://doi.org/10.1136/bmj.m4328 The BMJ, 371:m4328 Hetland, M L, Haavardsholm, E A, Rudin, A, Nordström, D, Nurmohamed, M, Gudbjornsson, B, Lampa, J, Hørslev-Petersen, K, Uhlig, T, Grondal, G, Østergaard, M, Heiberg, M S, Twisk, J, Lend, K, Krabbe, S, Hyldstrup, L H, Lindqvist, J, Hultgård Ekwall, A K, Grøn, K L, Kapetanovic, M, Faustini, F, Tuompo, R, Lorenzen, T, Cagnotto, G, Baecklund, E, Hendricks, O, Vedder, D, Sokka-Isler, T, Husmark, T, Ljoså, M K A, Brodin, E, Ellingsen, T, Söderbergh, A, Rizk, M, Olsson, Å R, Larsson, P, Uhrenholt, L, Just, S A, Stevens, D J, Laurberg, T B, Bakland, G, Olsen, I C, van Vollenhoven, R & NORD-STAR study group 2020, ' Active conventional treatment and three different biological treatments in early rheumatoid arthritis : phase IV investigator initiated, randomised, observer blinded clinical trial ', BMJ (Clinical research ed.), vol. 371, m4328 . https://doi.org/10.1136/bmj.m4328 The BMJ
BMJ Open Uhrenholt, L, Schlemmer, A, Hauge, E-M, Christensen, R, Dreyer, L, Suarez-Almazor, M E & Kristensen, S 2019, ' Dosage reduction and discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis : protocol for a pragmatic, randomised controlled trial (the BIOlogical Dose OPTimisation (BIODOPT) trial) ', BMJ Open, vol. 9, no. 7, e028517, pp. 1-11 . https://doi.org/10.1136/bmjopen-2018-028517 Uhrenholt, L, Schlemmer, A, Hauge, E M, Christensen, R, Dreyer, L, Suarez-Almazor, M E & Kristensen, S 2019, ' Dosage reduction and discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis : Protocol for a pragmatic, randomised controlled trial (the BIOlogical Dose OPTimisation (BIODOPT) trial) ', BMJ Open, vol. 9, no. 7, e028517 . https://doi.org/10.1136/bmjopen-2018-028517 Uhrenholt, L, Schlemmer, A, Hauge, E-M, Christensen, R, Dreyer, L, Suarez-Almazor, M E & Kristensen, S 2019, ' Dosage reduction and discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis : protocol for a pragmatic, randomised controlled trial (the BIOlogical Dose OPTimisation (BIODOPT) trial) ', BMJ Open, vol. 9, no. 7, e028517 . https://doi.org/10.1136/bmjopen-2018-028517